Kjell Titlestad

1.5k total citations
37 papers, 1.0k citations indexed

About

Kjell Titlestad is a scholar working on Biochemistry, Management of Technology and Innovation and Hematology. According to data from OpenAlex, Kjell Titlestad has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Biochemistry, 15 papers in Management of Technology and Innovation and 13 papers in Hematology. Recurrent topics in Kjell Titlestad's work include Blood transfusion and management (17 papers), Blood donation and transfusion practices (15 papers) and Blood groups and transfusion (11 papers). Kjell Titlestad is often cited by papers focused on Blood transfusion and management (17 papers), Blood donation and transfusion practices (15 papers) and Blood groups and transfusion (11 papers). Kjell Titlestad collaborates with scholars based in Denmark, Sweden and United States. Kjell Titlestad's co-authors include Klaus Rostgaard, Gustaf Edgren, Henrik Hjalgrim, Mads Melbye, Olof Nyrén, Eleftherios C. Vamvakas, T.J. Cobain, Marie Reilly, Hans Dieperink and Martin Tepel and has published in prestigious journals such as The Lancet, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Kjell Titlestad

36 papers receiving 1.0k citations

Peers

Kjell Titlestad
Eric A. Gehrie United States
Ruchika Goel United States
Kathleen Sazama United States
Elizabeth M. Love United Kingdom
Ira A. Shulman United States
Ronald A. Sacher United States
Erik A.M. Beckers Netherlands
Edward L. Wallace United States
Janice M. Nelson United States
Sheila MacLennan United Kingdom
Eric A. Gehrie United States
Kjell Titlestad
Citations per year, relative to Kjell Titlestad Kjell Titlestad (= 1×) peers Eric A. Gehrie

Countries citing papers authored by Kjell Titlestad

Since Specialization
Citations

This map shows the geographic impact of Kjell Titlestad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kjell Titlestad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kjell Titlestad more than expected).

Fields of papers citing papers by Kjell Titlestad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kjell Titlestad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kjell Titlestad. The network helps show where Kjell Titlestad may publish in the future.

Co-authorship network of co-authors of Kjell Titlestad

This figure shows the co-authorship network connecting the top 25 collaborators of Kjell Titlestad. A scholar is included among the top collaborators of Kjell Titlestad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kjell Titlestad. Kjell Titlestad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brodersen, Thorsten, Klaus Rostgaard, Cathrine Juel Lau, et al.. (2022). The healthy donor effect and survey participation, becoming a donor and donor career. Transfusion. 63(1). 143–155. 27 indexed citations
2.
Viberg, Bjarke, Per Hviid Gundtoft, Kjell Titlestad, et al.. (2021). Is tranexamic acid use in patients with a hip fracture safe?. The Bone & Joint Journal. 103-B(3). 449–455. 9 indexed citations
3.
Barnkob, Mike Bogetofte, Anton Pottegård, Henrik Støvring, et al.. (2020). Reduced prevalence of SARS-CoV-2 infection in ABO blood group O. Blood Advances. 4(20). 4990–4993. 98 indexed citations
4.
5.
6.
Dieperink, Hans, et al.. (2012). Should all adult patients with diarrhoea-associated HUS receive plasma exchange? – Authors' reply. The Lancet. 379(9815). 516–517. 1 indexed citations
7.
8.
Rasmussen, Kjeld Leisgård, et al.. (2011). Transfusion rate and prevalence of unexpected red blood cell alloantibodies in women undergoing hysterectomy for benign disease. Acta Obstetricia Et Gynecologica Scandinavica. 90(6). 636–641. 4 indexed citations
9.
Schousboe, Karoline, et al.. (2010). ABO-incompatible kidney transplantation.. PubMed. 57(10). A4197–A4197. 4 indexed citations
10.
Toftedal, Peter, et al.. (2010). Positive predictive value of serological diagnostic measures in celiac disease. Clinical Chemistry and Laboratory Medicine (CCLM). 48(5). 685–691. 30 indexed citations
11.
Johansson, Pär I., Kjell Titlestad, Bjarne Kuno Møller, & Henrik Ullum. (2009). [Overtransfusion--a bad Danish habit with serious consequences].. PubMed. 171(13). 1072–1072. 1 indexed citations
12.
Kamper‐Jørgensen, Mads, Gustaf Edgren, Klaus Rostgaard, et al.. (2009). Blood transfusion exposure in Denmark and Sweden. Transfusion. 49(5). 888–894. 20 indexed citations
13.
Kamper‐Jørgensen, Mads, Martin Ahlgren, Klaus Rostgaard, et al.. (2008). Survival after blood transfusion. Transfusion. 48(12). 2577–2584. 67 indexed citations
14.
Edgren, Gustaf, Marie Reilly, Henrik Hjalgrim, et al.. (2008). Donation Frequency, Iron Loss, and Risk of Cancer Among Blood Donors. JNCI Journal of the National Cancer Institute. 100(8). 572–579. 72 indexed citations
15.
Cobain, T.J., et al.. (2007). A survey of the demographics of blood use. Transfusion Medicine. 17(1). 1–15. 120 indexed citations
16.
Edgren, Gustaf, Henrik Hjalgrim, Marie Reilly, et al.. (2007). Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. The Lancet. 369(9574). 1724–1730. 56 indexed citations
17.
Larsen, Rune, Kjell Titlestad, Søren Thue Lillevang, et al.. (2005). Cesarean section: Is pretransfusion testing for red cell alloantibodies necessary?. Acta Obstetricia Et Gynecologica Scandinavica. 84(5). 448–455. 18 indexed citations
18.
Titlestad, Kjell. (2004). Clinical epidemiology of transfusion medicine. Transfusion and Apheresis Science. 32(1). 3–5. 3 indexed citations
19.
Titlestad, Kjell, Thomas Kielsgaard Kristensen, Jens Otto Lunde Jørgensen, & Jørgen Georgsen. (2002). Monitoring transfusion practice – a computerized procedure. Transfusion Medicine. 12(1). 25–34. 20 indexed citations
20.
Titlestad, Kjell, et al.. (1997). Detection of Irregular Red Cell Antibodies: More than 3 Years of Experience with a Gel Technique and Pooled Screening Cells. Vox Sanguinis. 73(4). 246–251. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric A. Gehrie Breakdown of academic impact, for papers by Ruchika Goel Breakdown of academic impact, for papers by Kathleen Sazama Breakdown of academic impact, for papers by Elizabeth M. Love Breakdown of academic impact, for papers by Ira A. Shulman Breakdown of academic impact, for papers by Ronald A. Sacher Breakdown of academic impact, for papers by Erik A.M. Beckers Breakdown of academic impact, for papers by Edward L. Wallace Breakdown of academic impact, for papers by Janice M. Nelson Breakdown of academic impact, for papers by Sheila MacLennan
Rankless by CCL
2026